We are live on ! Find out more
DIM

DLK Investment Management Portfolio holdings

AUM $235M
1-Year Est. Return 12.41%
This Fund
S&P 500
This Quarter Est. Return
+6.32%
1 Year Est. Return
+12.41%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$235M
AUM Growth
+$15.6M
Cap. Flow
+$5.27M
Cap. Flow %
2.24%
Top 10 Hldgs %
38.85%
Holding
113
New
7
Increased
49
Reduced
12
Closed
4

Sector Composition

Rank Sector Weight
1 Technology 19.46%
2 Healthcare 16.18%
3 Consumer Staples 12.99%
4 Industrials 12.88%
5 Financials 12.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GEHC icon
76
GE HealthCare
GEHC
$32.9B
$228K 0.1%
+2,513
New +$209K
VZ icon
77
Verizon
VZ
$196B
$213K 0.09%
+5,079
New +$205K
AMT icon
78
American Tower
AMT
$79B
$202K 0.09%
1,022
ADCT icon
79
ADC Therapeutics
ADCT
$150M
$149K 0.06%
33,155
EDIT icon
80
Editas Medicine
EDIT
$453M
$124K 0.05%
16,702
ZUO
81
DELISTED
Zuora, Inc.
ZUO
$108K 0.05%
11,800
ZIM icon
82
ZIM Integrated Shipping Services
ZIM
$2.96B
$104K 0.04%
10,257
CRNT icon
83
Ceragon Networks
CRNT
$199M
$96.6K 0.04%
30,200
PASG icon
84
Passage Bio
PASG
$14.5M
$86.4K 0.04%
3,200
RGTI icon
85
Rigetti Computing
RGTI
$6.04B
$84.5K 0.04%
55,250
CIFR icon
86
Cipher Digital
CIFR
$7.14B
$83.9K 0.04%
16,300
AG icon
87
First Majestic Silver
AG
$9.35B
$83.5K 0.04%
14,200
BDTX icon
88
Black Diamond Therapeutics
BDTX
$120M
$82.2K 0.03%
16,215
LYRA
89
DELISTED
LYRA THERAPEUTICS INC
LYRA
$74.6K 0.03%
240
BTCS icon
90
BTCS Inc
BTCS
$54.8M
$55.6K 0.02%
31,590
SPRO icon
91
Spero Therapeutics
SPRO
$71.2M
$53.9K 0.02%
31,355
HRTX icon
92
Heron Therapeutics
HRTX
$61.3M
$49.6K 0.02%
17,890
DM
93
DELISTED
Desktop Metal, Inc.
DM
$49K 0.02%
5,567
+626
+13% +$4.02K
ADAP
94
DELISTED
Adaptimmune Therapeutics
ADAP
$48.2K 0.02%
30,512
TIGR
95
UP Fintech Holding
TIGR
$849M
$46.4K 0.02%
13,501
QSI icon
96
Quantum-Si Incorporated
QSI
$179M
$33.5K 0.01%
17,000
SHPW
97
DELISTED
Shapeways Holdings, Inc. Common Stock
SHPW
$31.9K 0.01%
16,125
KEEL
98
Keel Infrastructure Corp
KEEL
$1.99B
$30.1K 0.01%
13,500
HOOK
99
DELISTED
HOOKIPA Pharma
HOOK
$22.8K 0.01%
3,200
DNA icon
100
Ginkgo Bioworks
DNA
$506M
$14.5K 0.01%
312

Similar funds

DLK Investment Management's Q1 2024 Portfolio in Review

As of Q1 2024, DLK Investment Management held 113 positions worth $235M, up 7.1% from $220M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

DLK Investment Management's Q1 2024 filing shows 7 new, 49 increased, 12 reduced and 4 closed positions. Its largest new stake was NVIDIA: 5,740 shares worth $519K. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.83M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Staples.

  • DLK Investment Management's largest Q1 2024 buy was NVIDIA: 5,740 shares worth $519K.
  • DLK Investment Management added most to Medtronic in Q1 2024, an estimated $790K increase.
  • DLK Investment Management's biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.83M.
  • DLK Investment Management fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2024, selling an estimated $392K.
  • DLK Investment Management's ten largest holdings make up 39% of its $235M portfolio in Q1 2024.
  • DLK Investment Management opened 7 new positions and closed 4 in Q1 2024.
  • DLK Investment Management's portfolio value rose 7.1% quarter-over-quarter to $235M.

Based on DLK Investment Management's 13F filing for Q1 2024, filed 12 Apr 2024.